Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 11 August 2011

Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Bazedoxifene; Drug: Bisphosphonate; Drug: Raloxifene
Sponsor: Pfizer
Enrolling by invitation - verified August 2011

Details: Last Updated: 11 August 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies